NCAM1 and X-linked Charcot-Marie-Tooth disease type 1: Importantly, treated Gjb1-null mice showed a significant amelioration in serum NCAM-1 levels compared to the mock group at 10 months of age, suggesting the potential value of this biomarker in CMT1X.